113 related articles for article (PubMed ID: 8137153)
1. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone.
Ogawa N; Asanuma M; Kondo Y; Hirata H; Nakayama N; Mori A
Brain Res; 1994 Jan; 633(1-2):167-70. PubMed ID: 8137153
[TBL] [Abstract][Full Text] [Related]
2. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
Kalivas PW; Stanley D; Prange AJ
Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats.
Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887
[TBL] [Abstract][Full Text] [Related]
4. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
[TBL] [Abstract][Full Text] [Related]
5. Role of central dopaminergic and 5-hydroxytryptaminergic projections in the behavioral responses elicited by thyrotropin-releasing hormone in rats.
Funk D; Post RM; Pert A
Psychopharmacology (Berl); 1997 Oct; 133(4):356-62. PubMed ID: 9372535
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.
Crespi F; Keane PE; Morre M
Exp Brain Res; 1986; 62(2):329-34. PubMed ID: 2423357
[TBL] [Abstract][Full Text] [Related]
7. TRH injected into the nucleus accumbens shell releases dopamine and reduces feeding motivation in rats.
Puga L; Alcántara-Alonso V; Coffeen U; Jaimes O; de Gortari P
Behav Brain Res; 2016 Jun; 306():128-36. PubMed ID: 27006143
[TBL] [Abstract][Full Text] [Related]
8. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
Miyamoto M; Nagawa Y
Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.
Del Arco A; Mora F; Mohammed AH; Fuxe K
J Neural Transm (Vienna); 2007 Feb; 114(2):185-93. PubMed ID: 16897609
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic intra-accumbens administration of the TRH analogue CG3509 on histamine-induced behaviour in the rat.
Bristow LJ; Bennett GW
Br J Pharmacol; 1989 Jul; 97(3):745-52. PubMed ID: 2503226
[TBL] [Abstract][Full Text] [Related]
11. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.
Steinpreis RE; Salamone JD
Brain Res; 1993 May; 612(1-2):263-70. PubMed ID: 8330204
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats.
Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K
Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205
[TBL] [Abstract][Full Text] [Related]
13. Administration of thyrotropin releasing hormone (TRH) to rats releases dopamine in n. accumbens but not n. caudatus.
Heal DJ; Green AR
Neuropharmacology; 1979 Jan; 18(1):23-31. PubMed ID: 105304
[No Abstract] [Full Text] [Related]
14. 17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain.
Di Paolo T; Rouillard C; Bédard P
Eur J Pharmacol; 1985 Nov; 117(2):197-203. PubMed ID: 4076343
[TBL] [Abstract][Full Text] [Related]
15. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
Yamada K; Demarest KT; Moore KE
Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
[TBL] [Abstract][Full Text] [Related]
16. Experimental evidence for sildenafil's action in the central nervous system: dopamine and serotonin changes in the medial preoptic area and nucleus accumbens during sexual arousal.
Kyratsas C; Dalla C; Anderzhanova E; Polissidis A; Kokras N; Konstantinides K; Papadopoulou-Daifoti Z
J Sex Med; 2013 Mar; 10(3):719-29. PubMed ID: 23157427
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo.
Kreutz MR; Acworth IN; Lehnert H; Wurtman RJ
Brain Res; 1990 Dec; 536(1-2):347-52. PubMed ID: 1707722
[TBL] [Abstract][Full Text] [Related]
18. CART peptide increases the mesolimbic dopaminergic neuronal activity: a microdialysis study.
Yang SC; Pan JT; Li HY
Eur J Pharmacol; 2004 Jun; 494(2-3):179-82. PubMed ID: 15212972
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide-dopamine interactions. IV. Effect of thyrotropin-releasing hormone on striatal dopaminergic neurons.
Ikegami H; Spahn SA; Prasad C
Peptides; 1989; 10(3):681-5. PubMed ID: 2528727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
